Dow Up 0.65% Nasdaq Up 0.41%

Stemline Therapeutics, Inc. (STML)

-NasdaqCM
14.01 Up 0.94(7.19%) 2:44PM EDT - Nasdaq Real Time Price
Prev Close:13.07
Open:13.08
Bid:14.03 x 100
Ask:14.11 x 100
1y Target Est:62.33
Beta:-4.709
Next Earnings Date:N/A
Day's Range:13.08 - 14.19
52wk Range:10.50 - 32.90
Volume:81,807
Avg Vol (3m):156,206
Market Cap:181.37M
P/E (ttm):N/A
EPS (ttm):-2.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for STML

Comparison

Symbol% ChgMkt Cap
STMLUp 7.19%181.37M
OMEDDown 2.09%614.54M
VSTMUp 5.08%243.30M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):792.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.39
Quarterly EPS Est (Sep-14) :-0.58
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback